癌症的CAR-T治疗:前景和挑战
Ran Chen1, Lei Chen2, Chaoqun Wang1
1Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China.
Frontiers in oncology
|December 20, 2023
概括
化学抗原受体 (CAR-T) 细胞疗法对固体瘤具有前景,但面临着瘤微环境的挑战. 目前正在开发新的策略,以克服这些障碍,并提高CAR-T疗法的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR-T) 细胞疗法在治疗血液性恶性瘤方面取得了显著的成功.
- 然而,它在固体瘤中的长期疗效受到复杂的瘤微环境 (TME) 的严重限制.
研究的目的:
- 审查关于CAR-T细胞癌症免疫疗法的当前研究和未来前景.
- 分析阻碍固体瘤CAR-T细胞治疗的障碍,并讨论克服这些障碍的策略.
主要方法:
- 传统免疫疗法和CAR-T细胞疗法的比较分析.
- 关于CAR-T细胞免疫疗法的最新进展的综述.
- 识别和分析TME中的障碍物,包括免疫抑制因素,代谢缺陷和物理障碍.
主要成果:
- TME带来了重大挑战,包括免疫抑制,代谢缺陷和阻碍CAR-T细胞功能的物理障碍.
- 新的治疗策略正在出现,以解决这些局限性,并提高CAR-T细胞在固体瘤中的持久性和活性.
结论:
- 克服与TME相关的障碍对于释放CAR-T细胞治疗在固体瘤中的全部潜力至关重要.
- 进一步研究先进的治疗策略和安全管理对于CAR-T免疫疗法的更广泛的临床应用至关重要.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


